2型糖尿病的妊娠结局:系统综述与荟萃分析
该系统综述与荟萃分析检索2009年1月1日至2024年PubMed,纳入47项队列观察研究,比较2型糖尿病(T2D)与1型糖尿病(T1D)、妊娠期糖尿病(GDM)及非糖尿病妊娠的结局。结果显示T2D较其他类型糖尿病妊娠围产期死亡率更高,与GDM和非糖尿病妊娠相比先天畸形、大于胎龄儿、死产等风险升高。
要点
- T2D妊娠较T1D妊娠新生儿死亡率(OR 2.29,95%CI 1.12-4.67)和围产期死亡率(OR 1.53,95%CI 1.20-1.94)更高。
- T2D妊娠较GDM妊娠死产风险显著升高(OR 16.55,95%CI 5.69-48.11),先天畸形、LGA、新生儿死亡率亦升高。
- 与GDM及非糖尿病妊娠相比,T2D妊娠的围产期不良结局风险更高,需加强医疗提供者和政策制定者的认识。
核心结论
- T2D妊娠与其他类型糖尿病妊娠相比围产期死亡率更高;鉴于T2D患病率上升,医疗提供者和政策制定者需提高对T2D相关不良妊娠结局的认识以改善照护。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed 2009年1月1日至2024年,纳入报告至少一项主要结局原始数据的10例及以上T2D妊娠的队列观察研究,同时收集比较性糖尿病和非糖尿病妊娠,PROSPERO注册号CRD42023411057,共分析47项研究。
主要发现
- 各分析中妊娠数因可用数据而异,范围为723至4,469,053例妊娠。
- 与T1D妊娠相比,T2D妊娠小于胎龄儿、新生儿死亡率(OR 2.29,95%CI 1.12-4.67)、围产期死亡率(OR 1.53,95%CI 1.20-1.94)更高。
- 与GDM妊娠相比,T2D妊娠先天畸形(OR 1.91,95%CI 1.04-3.50)、大于胎龄儿(OR 3.49,95%CI 2.49-4.89)、新生儿死亡率(OR 3.96,95%CI 3.38-4.64)、死产(OR 16.55,95%CI 5.69-48.11)更高。
- 与非糖尿病妊娠相比,T2D妊娠先天畸形(OR 1.76,95%CI 1.11-2.79)、大于胎龄儿(OR 2.79,95%CI 1.93-4.04)、围产期死亡率(OR 4.18,95%CI 2.91-6.01)、死产(OR 7.27,95%CI 3.01-17.53)更高。
关键数值与推荐
- 纳入标准:队列观察研究,报告至少一项主要结局(先天畸形、死产、新生儿和围产期死亡率、出生体重、大于胎龄儿率、小于胎龄儿率、巨大儿)的原始数据,且T2D妊娠≥10例。
- T2D vs T1D:小于胎龄儿、新生儿死亡率OR 2.29(95%CI 1.12-4.67)、围产期死亡率OR 1.53(95%CI 1.20-1.94)。
- T2D vs GDM:先天畸形OR 1.91(95%CI 1.04-3.50)、大于胎龄儿OR 3.49(95%CI 2.49-4.89)、新生儿死亡率OR 3.96(95%CI 3.38-4.64)、死产OR 16.55(95%CI 5.69-48.11)。
- T2D vs 非糖尿病妊娠:先天畸形OR 1.76(95%CI 1.11-2.79)、大于胎龄儿OR 2.79(95%CI 1.93-4.04)、围产期死亡率OR 4.18(95%CI 2.91-6.01)、死产OR 7.27(95%CI 3.01-17.53)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type 2 diabetes (T2D) now accounts for the majority of pre-existing diabetes affecting pregnancy in the UK. Our aim was to determine its impact on pregnancy outcomes compared to type 1 diabetes (T1D), gestational diabetes (GDM), and nondiabetes pregnancies. DATA SOURCES: PubMed was searched 1 January 2009 to 2024. STUDY ELIGIBILITY CRITERIA: Cohort observational studies reporting original data on at least one of the primary outcomes in ten or more T2D pregnancies were eligible for inclusion. Comparative diabetes and nondiabetes pregnancies were also collected. METHODS: Primary outcomes included congenital anomalies, stillbirths, neonatal and perinatal mortality, birthweight, rates of large for gestational age (LGA), small for gestational age (SGA), and macrosomia. PROSPERO ID CRD42023411057. RESULTS: Forty seven studies were analyzed. The number of pregnancies in each analysis varied depending on the available data from the outcome being analyzed but ranged from 723 to 4,469,053 pregnancies. When compared with T1D pregnancies, T2D were more likely to have SGA babies as well as greater neonatal and perinatal mortality (OR 2.29, 95% CI 1.12-4.67; OR 1.53 95% CI 1.20-1.94, and OR 1.31 95% CI 1.07-1.61, respectively). When compared with GDM, T2D were more likely to have babies with congenital anomalies (OR 1.91, 95% CI 1.04-3.50), LGA (OR 3.49, 95% CI 2.49-4.89), neonatal mortality (OR 3.96, 95% CI 3.38-4.64), and stillbirth (OR 16.55, 95% CI 5.69-48.11). In comparison to nondiabetic pregnancy, T2D were more likely to have babies with congenital anomalies (OR 1.76, 95% CI 1.11-2.79), LGA (OR 2.79, 95% CI 1.93-4.04), perinatal mortality (OR 4.18, 95% CI 2.91-6.01), and stillbirth (OR 7.27, 95% CI 3.01-17.53). CONCLUSION: T2D pregnancies are associated with a greater perinatal mortality than other forms of diabetes in pregnancy. Given its increasing prevenance, greater awareness of the adverse pregnancy outcomes associated with T2D is needed, by both healthcare providers and policy makers, to improve care.
引用
- Clement NS, Abul A, Farrelly R, et al. Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024. PMID: 39662865. doi:10.1016/j.ajog.2024.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。